Wall Street’s AI dream might be cracking under pressure, and 2025 could be the year it all cools off. Nvidia’s August stock ...

Some of the world's most dominant companies in high-growth markets, such as cloud computing and artificial intelligence, ...

T he NVIDIA SHIELD TV has been stuck on Android 11 forever now, but that might be about to change as the Android TV 14 beta ...

China’s antitrust investigation is a major change in how Beijing retaliates against U.S. tech policies, Reva Goujon writes in ...

Acer is not the only offender—looking at you, Microsoft, forcing your Copilot key onto keyboards—but the company has ...

Retail investors poured nearly $11 million into MicroStrategy's shares on Monday, almost three times their average daily ...

Miller-Howard Income-Equity portfolios performed well above the S&P 500. Click here to read the full commentary.

FNGU's performance has been driven by stocks like CrowdStrike and Netflix. Click here to read why FNGU ETF is currently rated ...

SoftBank-backed Perplexity AI has raised $500 million in its fourth funding round, tripling its valuation to $9 billion.

Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older Follows recent approval from China's National Medica ...